Codiak BioSciences, Inc. Proceeds from Common Stock Issued
Codiak BioSciences, Inc. reported Proceeds from Common Stock Issued of $20.62 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-11-03
- Codiak BioSciences, Inc. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $20.10M.
- Codiak BioSciences, Inc. proceeds from issuance of common stock for the quarter ending 2022-06-30 was -$67.00K.
- Codiak BioSciences, Inc. proceeds from issuance of common stock for the quarter ending 2022-03-31 was $589.00K, a 99.05% decline year-over-year.
- Codiak BioSciences, Inc. proceeds from issuance of common stock for the quarter ending 2021-12-31 was -$7.00K, a 100.01% decline year-over-year.
- Codiak BioSciences, Inc. proceeds from issuance of common stock for fiscal 2021 was $61.67M, a 17.05% decline from fiscal 2020.
- Codiak BioSciences, Inc. proceeds from issuance of common stock for fiscal 2020 was $74.35M.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock as first filed | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|---|
| 2022-09-30 | $20.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $20.03M derived: sum of 2 quarters · filed 2022-11-03 | $20.62M 10-Q · filed 2022-11-03 | $20.61M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2022-09-15 | $19.80M 10-Q · filed 2022-11-03 | |||||
| 2022-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $522.00K 10-Q · filed 2022-08-04 | $515.00K derived: sum of 3 quarters · filed 2022-08-04 | $515.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2022-03-31 | $589.00K 10-Q · filed 2022-05-05 | $582.00K derived: sum of 2 quarters · filed 2022-05-05 | $582.00K derived: sum of 3 quarters · filed 2022-11-03 | $59.00K derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$7.00K derived: sum of 2 quarters · filed 2022-11-03 | -$530.00K derived: sum of 3 quarters · filed 2022-11-03 | $61.67M 10-K · filed 2022-03-10 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$523.00K derived: sum of 2 quarters · filed 2022-11-03 | $61.68M 10-Q · filed 2022-11-03 | $137.20M derived: sum of 4 quarters · filed 2022-11-03 | ||
| 2021-06-30 | -$523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $61.68M 10-Q · filed 2022-08-04 | $137.20M derived: sum of 3 quarters · filed 2022-08-04 | |||
| 2021-03-31 | $62.20M 10-Q · filed 2022-05-05 | $137.72M derived: sum of 2 quarters · filed 2022-05-05 | ||||
| 2021-02-17 | $61.70M 10-Q · filed 2022-11-03 | $61.90M 10-Q · filed 2021-05-06 | ||||
| 2020-12-31 | $75.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $74.35M 10-K · filed 2022-03-10 | ||||
| 2020-10-16 | $74.40M 10-Q · filed 2022-11-03 | |||||
| 2020-09-30 | -$1.17M 10-Q · filed 2021-11-04 |